B Group Adds $12 Million to ADMA Biologics Despite a 58% Share Price Drop Over One Year
In May 2026, B Group increased its stake in ADMA Biologics by acquiring an additional 750,000 shares for approximately $11.84 million based on quarterly average pricing. Despite this investment, the stock has declined by nearly 58% over the past year and underperformed the S&P 500.
Tickers: $ADMA